Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
April 4, 2021 10:09 AM 4 min read

The Latest Picks And Pans From Barron's: Barrick Gold, BioNTech, Facebook, WW And More

by Nelson Hem Benzinga Staff Writer
Follow
FlipboardIcon version of the Flipboard logo
  • This weekend's Barron's cover story discusses a beleaguered social media giant that is still a buy.
  • Other featured articles share infrastructure picks, capital spending picks and a veteran fund manager's income picks.
  • Also, see the prospects for an up-and-coming biotech, a gold rebound play, a personal services provider and more.

Cover story "Like It or Not, Facebook Stock Is a Buy" by Max A. Cherney points out that social network Facebook, Inc. (NASDAQ:FB) has been beat up by controversy, and yet users and advertisers keep showing up. See why Barron's believes investors now have a chance to buy a growth story on the cheap. Could the stock see a gain of 20% or more in the next year?

See also: Benzinga's Bulls And Bears Of The Week: Apple, GM, JetBlue, Lululemon, Tesla And More

Also in this week's Barron's:

At the time of this writing, the author had no position in the mentioned equities.

Keep up with all the latest breaking news and trading ideas by following Benzinga on Twitter.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
MediaTrading Ideasamgenapplied materialsbarrick goldBarron'sCaterpillarCoca-colaFacebookSquareverizon communicationsWalgreensWells Fargo
ACM Logo
ACMAECOM
$94.06-%
Overview
AMAT Logo
AMATApplied Materials Inc
$319.24-1.69%
AMGN Logo
AMGNAmgen Inc
$369.49-0.01%
BNTX Logo
BNTXBioNTech SE
$99.60-1.87%
CAT Logo
CATCaterpillar Inc
$669.18-1.72%
FB Logo
FBProShares S&P 500 Dynamic Buffer ETF
Not Available-0.36%
GOLD Logo
GOLDGold.com Inc
$51.00-2.71%
KO Logo
KOCoca-Cola Co
$76.78-0.34%
SLB Logo
SLBSLB Ltd
$47.290.83%
VMC Logo
VMCVulcan Materials Co
$269.71-1.73%
VZ Logo
VZVerizon Communications Inc
$51.04-0.16%
WFC Logo
WFCWells Fargo & Co
$79.00-1.77%
WH Logo
WHWyndham Hotels & Resorts Inc
$76.77-%
WW Logo
WWWW International Inc
$22.00-2.09%

Daren Fonda's "Stocks That Could Gain the Most From Biden's Infrastructure Plan" discusses how many infrastructure plays have already run up, yet there could be further gains if the market sees a bill inching toward passage. Featured picks run the gamut from Aecom (NYSE:ACM) to Vulcan Materials Company (NYSE:VMC).

In "BioNTech Has Surged on Covid Vaccine. Its Next Big Hit Might Take a While," Josh Nathan-Kazis shows how BioNTech SE (NASDAQ:BNTX) CEO and co-founder Ugur Sahin intends to make this Germany-based biotech the next Amgen, Inc. (NASDAQ:AMGN) or Genentech.

Due to Bitcoin's growing acceptance as an alternative asset class and to higher Treasury rates, gold has lost some of its luster, according to "Gold Is Due for a Comeback. Barrick Is a Good Way to Play It" by Andrew Bary. Find out why Barron's thinks shares of mining giant Barrick Gold Corp (NYSE:GOLD) offer a cheap and attractive hedge against financial turmoil.

In Avi Salzman's "Americans Are Ready to Shed the Pandemic Pounds. This Stock Can Benefit," discover how WW International Inc (NYSE:WW), the former Weight Watchers, has weathered the lockdowns and shifted its focus to digital subscriptions. The article makes the case that this consumer stock is a healthy reopening play.

"American Road Trip: How the Motel Industry Grew Up" by Kenneth G. Pringle chronicles the growth of the motel industry from the start, as "ramshackle cabins" led to the modern offerings from Wyndham Hotels & Resorts Inc (NYSE:WH) and its peers. Find out how Holiday Inn reshaped the industry and spurred its growth.

Conditions are ideal for a pickup in capital expenditure — even before an infrastructure push. So says Jack Hough's "11 Stocks That Could Get a Shot in the Arm as Business Spending Gains." The featured picks include the likes of Applied Materials, Inc. (NASDAQ:AMAT), Caterpillar Inc. (NYSE:CAT) and Schlumberger NV (NYSE:SLB).

In "Fund Vet's Top Picks: 'Dogs,' Reopen Plays, REITs, and Preferreds," Lawrence C. Strauss reveals the latest ideas from a veteran fund manager who has spent much of his long career seeking income across stocks, bonds and other asset classes. Check out what the expert sees in Coca-Cola Co (NYSE:KO), Verizon Communications Inc. (NYSE:VZ), Walgreens Boots Alliance Inc (NASDAQ:WBA) and others.

Sarah Max's "It's a Great Time to Own Financial Stocks. Here's Why" suggests that the financial sector is poised to shine, notwithstanding the emergence of newly disruptive technologies. See whether Square Inc (NYSE:SQ) and Wells Fargo & Co (NYSE:WFC) are among those stocks that are worth a look now.

  • Whether good news could turn into bad news for investors
  • Big tech's role in the Biden infrastructure play
  • Whether the torrid market still has room to run
  • The case for liquid alternatives 2.0
  • A first-quarter roundup
  • How to choose a winning value exchange-traded fund
  • Whether unconstrained bond funds are the answer to rising interest rates
  • The COVID-19 technologies that could revolutionize health care
  • Whether new CDC sailing orders are good news for cruise lines
  • The 2021 surge in luxury hotel openings
  • Investing lessons from the Archegos crackup
ACM Logo
ACMAECOM
$94.06-%
Overview
AMAT Logo
AMATApplied Materials Inc
$319.24-1.69%
AMGN Logo
AMGNAmgen Inc
$369.49-0.01%
BNTX Logo
BNTXBioNTech SE
$99.60-1.87%
CAT Logo
CATCaterpillar Inc
$669.18-1.72%
FB Logo
FBProShares S&P 500 Dynamic Buffer ETF
Not Available-0.36%
GOLD Logo
GOLDGold.com Inc
$51.00-2.71%
KO Logo
KOCoca-Cola Co
$76.78-0.34%
SLB Logo
SLBSLB Ltd
$47.290.83%
VMC Logo
VMCVulcan Materials Co
$269.71-1.73%
VZ Logo
VZVerizon Communications Inc
$51.04-0.16%
WFC Logo
WFCWells Fargo & Co
$79.00-1.77%
WH Logo
WHWyndham Hotels & Resorts Inc
$76.77-%
WW Logo
WWWW International Inc
$22.00-2.09%
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter
Comments
Loading...